Allonnia is a bio-ingenuity company developing a bolt-on biotechnology solution to boost metal production from existing mining operations. Our D-Solve™ process selectively removes gangue and penalty minerals, such as Mg, Si, Ca, and Al, from ores and flotation concentrates using recyclable, biologically derived extractants. Integrated directly into existing flowsheets, D-Solve increases recovery, improves grade and reduces penalties. By enabling efficient processing of lower-grade ores, Allonnia helps miners unlock additional value while advancing operational efficiency. | Allonnia is a bio-ingenuity company dedicated to extracting value where others see waste. We believe elegant solutions to the world’s biggest environmental challenges will be found in the world’s smallest organisms. We’re pioneering novel approaches in biotechnology and engineering to solve waste challenges in nature, using nature. Allonnia is the exclusive North American distributor for the PFAS remediation technology, Surface Active Foam Fractionation (SAFF®) manufactured by EPOC Enviro, which removes long and short chain PFAS from water. They most recently launched 1,4 D-Stroy, a 1,4-dioxane bioremediation in situ solution, and announced the discovery of a patent pending PFAS biosensor that can detect the presence of PFAS and compliance down to parts per trillion. Learn more at https://allonnia.com/
Alexion, AstraZeneca Rare Disease
Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. | Alexion, AstraZeneca’s Rare Disease group, was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. For more information, please visit www.alexion.com. | Alexion, AstraZeneca Rare Disease, is the group within AstraZeneca focused on rare diseases, created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. As a leader in rare diseases for 30 years, Alexion is focused on serving patients and families affected by rare diseases and devastating conditions through the discovery, development and commercialization of life-changing medicines. Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology and ophthalmology. Headquartered in Boston, Massachusetts, Alexion has offices around the globe and serves patients in more than 50 countries. For more information, please visit www.alexion.com.
Akoya
Akoya provides a technology platform that enables financial institutions of all sizes to deliver secure and reliable access to financial data. Through a single integration with Akoya, financial institutions can use APIs to connect consumer-permissioned data to a wide range of data aggregators and fintechs. Akoya manages these connections and provides an interoperable solution designed to support data access across the financial services ecosystem.
Akeneo
Akeneo is the product experience (PX) company and global leader in Product Information Management (PIM). Akeneo empowers business leaders with software, education, and an engaged community all focused on the practice of product experience management. Leading brands, manufacturers, distributors, and retailers, including Chico’s, CarParts.com, TaylorMade Golf, Rail Europe, Kering, and more trust Akeneo to scale their commerce initiatives. Using Akeneo’s intelligent Product Cloud, companies can create elevated product experiences with user-friendly and AI-powered product data enrichment, management, syndication, and supplier data onboarding, and an app marketplace and partner network to meet business and buyer needs.
AcuityMD
AcuityMD is the MedTech intelligence platform that combines precise data, AI-powered insights, and intuitive workflows to help your team move faster and win more. Commercial teams across MedTech – from startups to global leaders – use AcuityMD to accelerate product adoption, grow revenue, and scale more efficiently. Whether you’re launching new innovations, expanding into new territories, or building stronger relationships with physicians, AcuityMD helps your team execute with confidence.
ACCURE Battery Intelligence
ACCURE is the leading provider of predictive analytics solutions for battery energy storage. We empower companies to reduce risk, enhance performance, and maximize the business value of their energy storage investments. Our advanced AI algorithms simplify the complexity of battery data, enabling safer, more reliable, and more sustainable operations. With deep expertise in battery technology and data analytics, we deliver unique clarity to energy storage management. Our solutions enable customers worldwide to optimize the performance and safety of their battery systems while minimizing costs and environmental impact. Visit accure.net to learn how you can achieve your energy storage goals. | ACCURE helps companies assess battery risk, ensuring safety and maximizing business value. By simplifying the complexity of battery data, our software makes batteries safer, more reliable, and more sustainable. Thru advanced cloud computing, ACCURE is bringing modern risk monitoring and assessing techniques to energy storage systems. We combine cutting-edge artificial intelligence and machine learning with deep expert knowledge of how batteries are used in across all types of energy storage systems. Today, we support customers from around the world helping to optimize the performance and safety of their battery systems. Visit us at accure.net.
a2z Radiology AI
At a2z Radiology AI, we’re revolutionizing radiology with our commitment to detecting everything from A to Z. Our mission is to create a safer, more reliable future where no disease is missed on imaging. We’re utilizing recent AI advancements to build custom models that simultaneously analyze multiple conditions, pushing the boundaries of what’s possible in radiology AI.
3Play Media
3Play Media is an integrated media accessibility and localization platform with patented solutions for closed captioning, transcription, live captioning, audio description, dubbing, and subtitling. 3Play Media combines AI with human review to provide innovative, highly accurate services at scale. Customers span multiple industries, including media & entertainment, corporate, e-commerce, fitness, higher education, government, and e-learning.Driven by innovation, we continuously refine our technology to enhance efficiency and accuracy while maintaining competitive pricing. With a user-friendly platform, swift turnaround times, and flexible APIs, we ensure seamless integration with video players and platforms, backed by robust security measures. 3Play Media empowers customers to engage global audiences, unlock new revenue streams, and deliver exceptional viewing experiences with industry-leading quality, speed, and scale.